Human Diagnostics Worldwide (HUMAN), EIKEN CHEMICAL CO., LTD. (EIKEN) and the Foundation for Innovative New Diagnostics (FIND) announced the launch of the first commercially available molecular diagnostic test for the detection of malaria caused by Plasmodium vivax parasites. Malaria-LAMP is a molecular test that works using loop-mediated isothermal amplification (LAMP), developed by EIKEN with exclusive distribution by HUMAN. FIND evaluated the prototype test in collaboration with the Hospital for Tropical Diseases in London, UK, and coordinated in-country clinical performance studies in Colombia and Peru.
Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| Point-of-care diagnostics for G6PD deficiency | 0 | 620 | October 5, 2019 | |
| A new point-of-care test to diagnose tuberculosis | 0 | 396 | July 30, 2019 | |
| Malaria Dx development - call for innovation | 0 | 329 | November 11, 2019 | |
| Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP | 0 | 573 | March 2, 2020 | |
| Trained dogs identify people with malaria parasites by their odour | 0 | 446 | May 24, 2019 |